ACARIZAX

house dust mite sublingual immunotherapy tablet · ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACARIZAX, covering 2017-01-30 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 [Phase 3]

See pricing